UBS Group’s Embecta EMBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.8M Sell
430,050
-200,944
-32% -$2.09M ﹤0.01% 4352
2025
Q4
$7.5M Buy
630,994
+421,254
+201% +$5.55M ﹤0.01% 3602
2025
Q3
$2.96M Sell
209,740
-164,133
-44% -$2.08M ﹤0.01% 4574
2025
Q2
$3.62M Sell
373,873
-11,536
-3% -$130K ﹤0.01% 4206
2025
Q1
$4.91M Sell
385,409
-417,457
-52% -$6.68M ﹤0.01% 3795
2024
Q4
$16.6M Buy
802,866
+749,363
+1,401% +$12.3M ﹤0.01% 2532
2024
Q3
$754K Buy
53,503
+33,086
+162% +$481K ﹤0.01% 4898
2024
Q2
$255K Sell
20,417
-42,813
-68% -$520K ﹤0.01% 5497
2024
Q1
$839K Buy
63,230
+16,902
+36% +$262K ﹤0.01% 4743
2023
Q4
$877K Buy
46,328
+17,957
+63% +$295K ﹤0.01% 4618
2023
Q3
$427K Sell
28,371
-29,295
-51% -$549K ﹤0.01% 4778
2023
Q2
$1.25M Buy
57,666
+14,417
+33% +$393K ﹤0.01% 4024
2023
Q1
$1.22M Buy
43,249
+4,241
+11% +$120K ﹤0.01% 3932
2022
Q4
$987K Buy
39,008
+11,000
+39% +$336K ﹤0.01% 4087
2022
Q3
$806K Sell
28,008
-4,122
-13% -$122K ﹤0.01% 3932
2022
Q2
$814K Buy
+32,130
New +$926K ﹤0.01% 3892

Other funds holding EMBC

UBS Group's EMBC Position: Q1 2026 in Review

UBS Group reduced its Embecta (EMBC) stake by 32% in Q1 2026, selling an estimated $2.09M and leaving 430,050 shares worth $3.8M. The position accounts for ﹤0.01% of the portfolio, ranked #4352.

UBS Group first reported a position in EMBC in Q2 2022 and has held it in 16 quarters since. The position peaked at $16.6M in Q4 2024. 337 funds tracked by Wall St. Rank hold EMBC as of Q1 2026.

  • UBS Group held 430,050 shares of Embecta worth $3.8M as of Q1 2026.
  • UBS Group sold 200,944 Embecta shares in Q1 2026, an estimated $2.09M.
  • Embecta made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #4352 holding.
  • UBS Group first reported a position in Embecta in Q2 2022 and has held it in 16 quarters since.
  • UBS Group's Embecta position peaked at $16.6M in Q4 2024.
  • 337 funds tracked by Wall St. Rank held Embecta as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.